Lack of effect of risperidone on core autistic symptoms: Data from a longitudinal study

Journal of Child and Adolescent Psychopharmacology

Volumn 24, Issue 9, 2014, Pages 513-518

  Marrus, Natasha ^a   Underwood Riordan, Heather ^b   Randall, Fellana ^a   Zhang, Yi ^a   Constantino, John N ^a  

^a WASHINGTON UNIVERSITY   (United States)

^b UNIVERSITY OF MISSOURI ST LOUIS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RISPERIDONE;

ADAPTIVE BEHAVIOR; AGGRESSION; AGGRESSIVENESS; ANXIETY; ARTICLE; AUTISM; AWARENESS; CHILD; CLINICAL ARTICLE; FEMALE; GESTURE; HUMAN; INTELLIGENCE QUOTIENT; INTERPERSONAL COMMUNICATION; IRRITABILITY; LONGITUDINAL STUDY; MALE; MOTIVATION; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; QUANTITATIVE ANALYSIS; SOCIAL COGNITION; SOCIAL RESPONSIVENESS SCALE; TREATMENT RESPONSE; WEIGHT GAIN; AUTISTIC DISORDER; DRUG EFFECTS; PARENT; PRESCHOOL CHILD; PSYCHOLOGY; SEVERITY OF ILLNESS INDEX;

AGGRESSION; AUTISTIC DISORDER; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; PARENTS; RISPERIDONE; SEVERITY OF ILLNESS INDEX;

EID: 84911500685     PISSN: 10445463     EISSN: 15578992     Source Type: Journal    
DOI: 10.1089/cap.2014.0055     Document Type: Article

References (30)

1. Achenbach TM: Integrative Guide for the 1991 CBCL 4-18 YSR and TRF Profiles. Burlington, VT: University of Vermont Department of Psychiatry, 1991.
2. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 5th ed. Washington, DC: American Psychiatric Association; 2013.
3. Arnold LE, Vitiello B, McDougle C, Scahill L, Shah B, Gonzalez NM, Chuang S, Davies M, Hollway J, Aman MG, Cronin P, Koenig K, Kohn AE, McMahon DJ, Tierney E: Parent-defined target symptoms respond to risperidone in RUPP autism study: Customer approach to clinical trials. J Am Acad Child Adolesc Psychiatry 42:1443-1450, 2003.
4. Capone GT, Goyal P, Grados M, Smith B, Kammann H: Risperidone use in children with Down syndrome, severe intellectual disability, and comorbid autistic spectrum disorders: A naturalistic study. J Dev Behav Pediatr 29:106-116, 2008.
5. Centers for Disease Control and Prevention: Prevalence of autism spectrum disorders - Autism and Developmental Disabilities Monitoring Network, 14 sites, United States, 2008. MMWR Surveill Summ 61:1-19, 2012.
6. Constantino J, Gruber C: The Social Responsiveness Scale, 2nd ed. Torrance, CA: Western Psychological Services: 2012.
7. Constantino JN, Abbacchi AM, Lavesser PD, Reed H, Givens L, Chiang L, Gray T, Gross M, Zhang Y, Todd RD: Developmental course of autistic social impairment in males. Dev Psychopathol 21:127-138, 2009.
8. Constantino JN, Davis SA, Todd RD, Schindler MK, Gross MM, Brophy SL, Metzger LM, Shoushtari CS, Splinter R, Reich W: Validation of a brief quantitative measure of autistic traits: Comparison of the social responsiveness scale with the autism diagnostic interview-revised. J Autism Dev Disord, 33:427-433, 2003.
9. Constantino JN, Gruber CP, Davis S, Hayes S, Passanante N, Przybeck, T: The factor structure of autistic traits. J Child Psychol Psychiatry 45:719-726, 2004.
10. Constantino JN, Przybeck T, Friesen D, Todd RD: Reciprocal social behavior in children with and without pervasive developmental disorders. J Dev Behav Pediatr, 21:2-11, 2000.
11. Frazier TW, Ratliff KR, Gruber C, Zhang Y, Law PA, Constantino JN: Confirmatory factor analytic structure and measurement invariance of quantitative autistic traits measured by the Social Responsiveness Scale-2. Autism 18:31-44, 2014.
12. Gencer O, Emiroglu FN, Miral S, Baykara B, Baykara A, Dirik E: Comparison of long-term efficacy and safety of risperidone and haloperidol in children and adolescents with autistic disorder. An open label maintenance study. Eur Child Adolesc Psychiatry, 17:217-225, 2008.
13. Jesner OS, Aref-Adib M, Coren E: Risperidone for autism spectrum disorder. Cochrane Database Syst Rev 1:CD005040, 2007.
14. Klaiman C, Huffman L, Masaki L, Elliott GR: Tetrahydrobiopterin as a treatment for autism spectrum disorders: A double-blind, placebo-controlled trial. J Child Adolesc Psychopharmacol 23:320-328, 2013.
15. Laugeson EA, Ellingsen R, Sanderson J, Tucci L, Bates S: The ABC's of teaching social skills to adolescents with autism spectrum disorder in the classroom: The UCLA PEERS® Program. J Autism Dev Disord 44:2244-2256, 2014.
16. Lemmon ME, Gregas M, Jeste SS: Risperidone use in autism spectrum disorders: A retrospective review of a clinic-referred patient population. J Child Neurol, 26: 428-432, 2011.
17. Luby J, Mrakotsky C, Stalets MM, Belden A, Heffelfinger A, Williams M, Spitznagel E: Risperidone in preschool children with autistic spectrum disorders: an investigation of safety and efficacy. J Child Adolesc Psychopharmacol, 16:575-587, 2006.
18. Masi G, Cosenza A, Mucci M, Brovedani P: A 3-year naturalistic study of 53 preschool children with pervasive developmental disorders treated with risperidone. J Clin Psychiatry 64:1039-1047, 2003.
19. McCracken JT, McGough J, Shah B, Cronin P, Hong D, Aman MG, Arnold LE, Lindsay R, Nash P, Hollway J, McDougle CJ, Posey D, Swiezy N, Kohn A, Scahill L, Martin A, Koenig K, Volkmar F, Carroll D, Lancor A, Tierney E, Ghuman J, Gonzalez NM, Grados M, Vitiello B, Ritz L, Davies M, Robinson J, McMahon D: Risperidone in children with autism and serious behavioral problems. N Engl J Med 347:314-321, 2002.
20. McDougle CJ, Scahill L, Aman MG, McCracken JT, Tierney E, Davies M, Arnold LE, Posey DJ, Martin A, Ghuman JK, Shah B, Chuang SZ, Swiezy NB, Gonzalez NM, Hollway J, Koenig K, McGough JJ, Ritz L, Vitiello B: Risperidone for the core symptom domains of autism: results from the study by the autism network of the research units on pediatric psychopharmacology. Am J Psychiatry 162: 1142-1148, 2005.
21. McPheeters ML, Warren Z, Sathe N, Bruzek JL, Krishnaswami S, Jerome RN, Veenstra-Vanderweele J: A systematic review of medical treatments for children with autism spectrum disorders. Pediatrics 127: e1312-1321, 2011.
22. Miral S, Gencer O, Inal-Emiroglu FN, Baykara B, Baykara A, Dirik E: Risperidone versus haloperidol in children and adolescents with AD: A randomized, controlled, double-blind trial. Eur Child Adolesc Psychiatry 17:1-8, 2008.
23. Nagaraj R, Singhi P, Malhi P: Risperidone in children with autism: Randomized, placebo-controlled, double-blind study. J Child Neurol 21:450-455, 2006.
24. Pandina GJ, Bossie CA, Youssef E, Zhu Y, Dunbar F: Risperidone improves behavioral symptoms in children with autism in a randomized, double-blind, placebo-controlled trial. J Autism Dev Disord 37:367-373, 2007.
25. Scahill L, Hallett V, Aman MG, McDougle CJ, Eugene Arnold L, McCracken JT, Tierney E, Deng Y, Dziura J, Vitiello B: Brief Report: Social disability in autism spectrum disorder: Results from Research Units on Pediatric Psychopharmacology (RUPP) Autism Network trials. J Autism Dev Disord 43:739-746, 2013.
26. Scahill L, McDougle CJ, Aman MG, Johnson C, Handen B, Bearss K, Dziura J, Butter E, Swiezy NG, Arnold LE, Stigler KA, Sukhodolsky DD, Lecavalier L, Pozdol SL, Nikolov R, Hollway JA, Korzekwa P, Gavaletz A, Kohn AE, Koenig K, Grinnon S, Mulick JA, Yu S, Vitiello B: Effects of risperidone and parent training on adaptive functioning in children with pervasive developmental disorders and serious behavioral problems. J Am Acad Child Adolesc Psychiatry 51:136-146, 2012.
27. Shea S, Turgay A, Carroll A, Schulz M, Orlik H, Smith I, Dunbar F: Risperidone in the treatment of disruptive behavioral symptoms in children with autistic and other pervasive developmental disorders. Pediatrics 114:e634-641, 2004.
28. Troost PW, Lahuis BE, Steenhuis MP, Ketelaars CE, Buitelaar JK, van Engeland H, Scahill L, Minderaa RB, Hoekstra PJ: Long-term effects of risperidone in children with autism spectrum disorders: A placebo discontinuation study. J Am Acad Child Adolesc Psychiatry 44:1137-1144, 2005.
29. Williams SK, Scahill L, Vitiello B, Aman MG, Arnold LE, McDougle CJ, McCracken JT, Tierney E, Ritz L, Posey DJ, Swiezy NB, Hollway J, Cronin P, Ghuman J, Wheeler C, Cicchetti D, Sparrow S: Risperidone and adaptive behavior in children with autism. J Am Acad Child Adolesc Psychiatry 45:431-439, 2006.
30. Zuddas A, Di Martino A, Muglia P, Cianchetti C: Long-term risperidone for pervasive developmental disorder: Efficacy, tolerability, and discontinuation. J Child Adolesc Psychopharmacol 10:79-90, 2000.